Literature DB >> 22271740

A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease.

R J Hinchliffe1, G Andros, J Apelqvist, K Bakker, S Friederichs, S Fiedrichs, J Lammer, M Lepantalo, J L Mills, J Reekers, C P Shearman, G Valk, R E Zierler, N C Schaper.   

Abstract

In several large recent observational studies, peripheral arterial disease (PAD) was present in up to 50% of the patients with a diabetic foot ulcer and was an independent risk factor for amputation. The International Working Group on the Diabetic Foot therefore established a multidisciplinary working group to evaluate the effectiveness of revascularization of the ulcerated foot in patients with diabetes and PAD. A systematic search was performed for therapies to revascularize the ulcerated foot in patients with diabetes and PAD from 1980-June 2010. Only clinically relevant outcomes were assessed. The research conformed to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, and the Scottish Intercollegiate Guidelines Network methodological scores were assigned. A total of 49 papers were eligible for full text review. There were no randomized controlled trials, but there were three nonrandomized studies with a control group. The major outcomes following endovascular or open bypass surgery were broadly similar among the studies. Following open surgery, the 1-year limb salvage rates were a median of 85% (interquartile range of 80-90%), and following endovascular revascularization, these rates were 78% (70.5-85.5%). At 1-year follow-up, 60% or more of ulcers had healed following revascularization with either open bypass surgery or endovascular revascularization. Studies appeared to demonstrate improved rates of limb salvage associated with revascularization compared with the results of medically treated patients in the literature. There were insufficient data to recommend one method of revascularization over another. There is a real need for standardized reporting of baseline demographic data, severity of disease and outcome reporting in this group of patients.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22271740     DOI: 10.1002/dmrr.2249

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  37 in total

Review 1.  Diagnostics and treatment of the diabetic foot.

Authors:  Jan Apelqvist
Journal:  Endocrine       Date:  2012-02-25       Impact factor: 3.633

2.  Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations.

Authors:  Jeremy D Darling; John C McCallum; Peter A Soden; Raul J Guzman; Mark C Wyers; Allen D Hamdan; Hence J Verhagen; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2017-01-07       Impact factor: 4.268

Review 3.  Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes.

Authors:  Thejasvi Thiruvoipati; Caitlin E Kielhorn; Ehrin J Armstrong
Journal:  World J Diabetes       Date:  2015-07-10

4.  The Diagnosis and Treatment of Peripheral Arterial Vascular Disease.

Authors:  Holger Lawall; Peter Huppert; Christine Espinola-Klein; Gerhard Rümenapf
Journal:  Dtsch Arztebl Int       Date:  2016-10-28       Impact factor: 5.594

Review 5.  Preventing and treating foot complications associated with diabetes mellitus.

Authors:  Frank L Bowling; S Tawqeer Rashid; Andrew J M Boulton
Journal:  Nat Rev Endocrinol       Date:  2015-08-18       Impact factor: 43.330

6.  Oximetric angiosome imaging in diabetic feet.

Authors:  Jie Zheng; David Muccigrosso; Xiaodong Zhang; Hongyu An; Andrew R Coggan; Bashir Adil; Charles F Hildebolt; Chandu Vemuri; Patrick Geraghty; Mary K Hastings; Michael J Mueller
Journal:  J Magn Reson Imaging       Date:  2016-03-10       Impact factor: 4.813

Review 7.  The Diabetic Foot: A Historical Overview and Gaps in Current Treatment.

Authors:  Caroline C L M Naves
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-05-01       Impact factor: 4.730

8.  Comprehensive approach to management of critical limb ischemia.

Authors:  Lanfroi Graziani
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-09

9.  Treatment of hind limb ischemia using angiogenic peptide nanofibers.

Authors:  Vivek A Kumar; Qi Liu; Navindee C Wickremasinghe; Siyu Shi; Toya T Cornwright; Yuxiao Deng; Alon Azares; Amanda N Moore; Amanda M Acevedo-Jake; Noel R Agudo; Su Pan; Darren G Woodside; Peter Vanderslice; James T Willerson; Richard A Dixon; Jeffrey D Hartgerink
Journal:  Biomaterials       Date:  2016-04-26       Impact factor: 12.479

10.  Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105.

Authors:  Hakan Orbay; Yin Zhang; Hao Hong; Timothy A Hacker; Hector F Valdovinos; James A Zagzebski; Charles P Theuer; Todd E Barnhart; Weibo Cai
Journal:  Mol Pharm       Date:  2013-06-17       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.